From: In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus
Strain
Agent
Minimal inhibitory concentration (μg/ml)
FICI
Outcome
Alone
Combination
MRSA
ATCC
43300
Tanreqing
Vancomycin
4125
2.5
2063
1.25
1
Addition
Linezolid
516
0.625